{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T03:55:20Z","timestamp":1770609320019,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Felty\u2019s syndrome (FS) is characterized by the triad of rheumatoid arthritis (RA), splenomegaly and neutropenia. The arthritis is typically severe and virtually always associated with high-titer rheumatoid factor. The presence of persistent neutropenia is generally required to make the diagnosis. Most patients diagnosed with FS are aged 50\u201370\u2009years and have had RA for more than 10\u2009years. It is rarely seen in patients with juvenile idiopathic arthritis (JIA), with only five cases having been reported throughout the world.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>The present study describes the case of a 14-year-old female with a seven-year history of polyarticular JIA, presenting with splenomegaly, hepatomegaly, cholestasis and thrombocytopenia. However, she occasionally developed neutropenia. Titers of rheumatoid factor and anti-CCP were persistently high, and the antinuclear antibody titer was 1:320, while the antibody results for anti-dsDNA and anti-Sm were negative. Serum levels of IgA, IgG, IgM and IgE were all persistently elevated, and the ratio of CD19<jats:sup>+<\/jats:sup> lymphocytes in the subgroups of lymphocytes was persistently high. The level of complements was normal. No STAT3 and STAT5B mutations were found by next-generation sequencing. The patient did not respond to methotrexate, prednisolone, hydroxychloroquine (HCQ), sulfasalazine and etanercept but was responsive to rituximab.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>JIA, thrombocytopenia and splenomegaly are the most common and important features in six children with FS, while persistent neutropenia is not seen in all these patients. No complement deficiency has been found in children with FS so far. Manifestations of FS without neutropenia may be extremely rare. There are differences between adults and children in the clinical and laboratory features of FS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12887-020-02054-4","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T10:02:35Z","timestamp":1586253755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phenotypic variability in a child with Felty\u2019s syndrome: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Guo-min","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-zhen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"2054_CR1","first-page":"473","volume":"31","author":"H Maccormac","year":"1938","unstructured":"Maccormac H. Chauffard-still-Felty syndrome. Proc R Soc Med. 1938;31:473\u20134.","journal-title":"Proc R Soc Med"},{"key":"2054_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1874312901408010129","volume":"8","author":"MB Owlia","year":"2014","unstructured":"Owlia MB, Newman K, Akhtari M. Felty's syndrome, insights and updates. Open Rheumatol J. 2014;8:129\u201336.","journal-title":"Open Rheumatol J"},{"key":"2054_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","volume":"69","author":"G Campion","year":"1990","unstructured":"Campion G, Maddison PJ, Goulding N, James I, Ahern MJ, Watt I, et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine. 1990;69:69\u201380.","journal-title":"Medicine"},{"key":"2054_CR4","first-page":"835","volume":"11","author":"AM Rosenberg","year":"1984","unstructured":"Rosenberg AM, Mitchell DM, Card RT. Felty's syndrome in a child. J Rheumatol. 1984;11:835\u20137.","journal-title":"J Rheumatol"},{"key":"2054_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0022-3476(85)80299-7","volume":"106","author":"K Toomey","year":"1985","unstructured":"Toomey K, Hepburn B. Felty syndrome in juvenile arthritis. J Pediatr. 1985;106:254\u20135.","journal-title":"J Pediatr"},{"key":"2054_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00043426-199809000-00022","volume":"20","author":"BJ Bloom","year":"1998","unstructured":"Bloom BJ, Smith P, Alario AJ. Felty syndrome complicating juvenile rheumatoid arthritis. J Pediatr Hematol Oncol. 1998;20:511\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2054_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1442-200x.2005.02093.x","volume":"47","author":"CH Lee","year":"2005","unstructured":"Lee CH, Han SH, Yoon BY, Lee YW. A case of adult-onset Felty syndrome in juvenile rheumatoid arthritis. Pediatr Int. 2005;47:463\u20135.","journal-title":"Pediatr Int"},{"key":"2054_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/ol.2013.1779","volume":"7","author":"RZ Xiao","year":"2014","unstructured":"Xiao RZ, Xiong MJ, Long ZJ, Fan RF, Lin DJ. Diagnosis of Felty's syndrome, distinguished from hematological neoplasm: a case report. Oncol Lett. 2014;7:713\u20136.","journal-title":"Oncol Lett"},{"issue":"105\u2013109","key":"2054_CR9","first-page":"118","volume":"26","author":"W Woolston","year":"2017","unstructured":"Woolston W, Connelly LM. Felty's syndrome: a qualitative case study. Medsurg Nurs. 2017;26(105\u2013109):118.","journal-title":"Medsurg Nurs"},{"key":"2054_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","volume":"18","author":"GP Balint","year":"2004","unstructured":"Balint GP, Balint PV. Felty\u2019s syndrome. Best Pract Res Clin Rheumatol. 2004;18:631\u201345.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2054_CR11","first-page":"2737","volume":"28","author":"L Berntson","year":"2001","unstructured":"Berntson L, Fasth A, Andersson-G\u00e4re B, Kristinsson J, Lahdenne P, et al. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology European League Against Rheumatism. J Rheumatol. 2001;28:2737\u201343.","journal-title":"J Rheumatol"},{"key":"2054_CR12","first-page":"305","volume":"24","author":"M Calguneri","year":"2006","unstructured":"Calguneri M, Ureten K, Ozturk MA, Onat AM, Ertenli I, Kiraz S, et al. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol. 2006;24:305\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"2054_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10067-012-2157-3","volume":"32","author":"A Rozin","year":"2013","unstructured":"Rozin A, Hoffman R, Hayek T, Balbir-Gurman A. Felty\u2019s syndrome without rheumatoid arthritis? Clin Rheumatol. 2013;32:701\u20134.","journal-title":"Clin Rheumatol"},{"key":"2054_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/1757-1626-2-206","volume":"2","author":"D Chavalitdhamrong","year":"2009","unstructured":"Chavalitdhamrong D, Molovic-Kokovic A, Iliev A. Felty\u2019s syndrome as an initial presentation of rheumatoid arthritis: a case report. Cases J. 2009;2:206.","journal-title":"Cases J"},{"key":"2054_CR15","first-page":"435","volume":"73","author":"T Jain","year":"2015","unstructured":"Jain T, Mittal C, Sengupta R, Rubin B. Non-articular Felty's syndrome: an uncommon diagnosis. Neth J Med. 2015;73:435\u20136.","journal-title":"Neth J Med"},{"key":"2054_CR16","first-page":"257","volume":"1","author":"JD Bradley","year":"1983","unstructured":"Bradley JD, Pinals RS. Felty's syndrome presenting without arthritis. Clin Exp Rheumatol. 1983;1:257\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"2054_CR17","doi-asserted-by":"crossref","unstructured":"Aslam F, Cheema RS, Feinstein M, Chang-Miller A. Neutropaenia and splenomegaly without arthritis: think rheumatoid arthritis. BMJ Case Rep. 2018. bcr-2018-225359.","DOI":"10.1136\/bcr-2018-225359"},{"key":"2054_CR18","first-page":"156","volume":"141","author":"JL Spivak","year":"1977","unstructured":"Spivak JL. Felty's syndrome: an analytical review. Johns Hopkins Med J. 1977;141:156\u201362.","journal-title":"Johns Hopkins Med J"},{"key":"2054_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/annrheumdis-2013-203844","volume":"73","author":"N Dwivedi","year":"2014","unstructured":"Dwivedi N, Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis. 2014;73:483\u201391.","journal-title":"Ann Rheum Dis"},{"key":"2054_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1398-9995.1981.tb01875.x","volume":"36","author":"EM Egeskjold","year":"1981","unstructured":"Egeskjold EM, Permin H, Nielsen I, S\u00f8rensen HJ, Osterballe O, Kallerup HE. Anti-IgG antibodies and antinuclear antibodies in allergic patients. Allergy. 1981;36:573\u201381.","journal-title":"Allergy"},{"key":"2054_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1398-9995.1982.tb02321.x","volume":"37","author":"H Permin","year":"1982","unstructured":"Permin H, Egeskjold EM. IgE anti-IgG antibodies in patients with juvenile and adult rheumatoid arthritis including Felty's syndrome. Allergy. 1982;37:421\u20137.","journal-title":"Allergy"},{"key":"2054_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","volume":"37","author":"S Wassenberg","year":"1998","unstructured":"Wassenberg S, Herborn G, Rau R. Methotrexate treatment in Felty's syndrome. Br J Rheumatol. 1998;37:908\u201311.","journal-title":"Br J Rheumatol"},{"key":"2054_CR23","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.3324\/haematol.11819","volume":"92","author":"M Mah\u00e9vas","year":"2007","unstructured":"Mah\u00e9vas M, Audia S, De Lastours V, Michel M, Bonotte B, Godeau B. Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine. Haematologica. 2007;92:e78\u20139.","journal-title":"Haematologica"},{"key":"2054_CR24","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/ard.2004.032110","volume":"64","author":"A Ghavami","year":"2005","unstructured":"Ghavami A, Genevay S, Fulpius T, Gabay C. Etanercept in treatment of Felty's syndrome. Ann Rheum Dis. 2005;64:1090\u20131.","journal-title":"Ann Rheum Dis"},{"key":"2054_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/1874312901206010312","volume":"6","author":"L Heylen","year":"2012","unstructured":"Heylen L, Dierickx D, Vandenberghe P, Westhovens R. Targeted therapy with rituximab in Felty's syndrome: a case report. Open Rheumatol J. 2012;6:312\u20134.","journal-title":"Open Rheumatol J"},{"key":"2054_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jbspin.2008.02.018","volume":"75","author":"E Shipley","year":"2008","unstructured":"Shipley E, H\u00e9raud A, Hennette A, Vernhes JP. Efficacy of rituximab in Felty's syndrome. Joint Bone Spine. 2008;75:621\u20132.","journal-title":"Joint Bone Spine"},{"key":"2054_CR27","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JC Edwards","year":"2004","unstructured":"Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572\u201381.","journal-title":"N Engl J Med"},{"key":"2054_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3324\/haematol.2014.113142","volume":"100","author":"HL Rajala","year":"2015","unstructured":"Rajala HL, Olson T, Clemente MJ, Lagstr\u00f6m S, Ellonen P, Lundan T, et al. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Haematologica. 2015;100:91\u20139.","journal-title":"Haematologica"},{"key":"2054_CR29","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","volume":"121","author":"HL Rajala","year":"2013","unstructured":"Rajala HL, Eldfors S, Kuusanmaki H, van Adrichem AJ, Olson T, Lagstr\u00f6m S, et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 2013;121:4541\u201350.","journal-title":"Blood"},{"key":"2054_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3324\/haematol.2017.175729","volume":"103","author":"P Savola","year":"2018","unstructured":"Savola P, Br\u00fcck O, Olson T, Kelkka T, Kauppi MJ, Kovanen PE, et al. Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia. Haematologica. 2018;103:304\u201312.","journal-title":"Haematologica"},{"key":"2054_CR31","doi-asserted-by":"publisher","first-page":"15869","DOI":"10.1038\/ncomms15869","volume":"8","author":"P Savola","year":"2017","unstructured":"Savola P, Kelkka T, Rajala HL, Kuuliala A, Kuuliala K, Eldfors S, et al. Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis. Nat Commun. 2017;8:15869.","journal-title":"Nat Commun"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02054-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-020-02054-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02054-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:17:29Z","timestamp":1617751049000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-02054-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-02054-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patients\u2019 parents provided written informed consent. Ethics board approval and consent was obtained for this work from the Ethics Committee at the Children\u2019s Hospital of Fudan University, Shanghai, China (ekyy-2011-69).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parent for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}